The global interest in medical weight loss solutions has surged, driven by the success stories and clinical efficacy of medications like Ozempic and Wegovy. Originally developed for managing Type 2 ...

Ozempic teeth is the latest concern associated with the ‘miracle’ weight loss drug Ozempic Read to know more about this side ...

Obesity is a major health concern in the world, as millions of people have excessive fat deposits in their bodies. In 2022, 890 million people were found to be living with obesity, according to the ...

While employers aren’t yet reimbursing weight loss drugs en masse, significantly reduced net costs could affect their future ...

The Pharma world is seeing a big opportunity in GLP-1s – the new innovative fast emerging drugs for diabetes & obesity. Kiran ...

TUCSON, AZ / ACCESS Newswire / June 2, 2025 / Umbrella Labs, a leading supplier of advanced research chemicals, announced the expansion of its peptide catalog to include Retatrutide (LY3437943), an ...

For adults with diabetes and obesity, GLP-1 RAs are associated with a reduced risk for obesity-related cancer compared with DPP-4 inhibitors.

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Insulin efsitora alfa (investigational once-weekly basal insulin): In another ADA-sponsored symposium, Lilly will share results from the QWINT-1, QWINT-3 and QWINT-4 Phase 3 trials, which evaluated ...

In response to the proposal presented by the Dr Reddy's Laboratories, the Subject Expert Committee (SEC) functional under the ...